Search results
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 7 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 18 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 15 hours agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 15 hours agoThe Cambridge, Massachusetts-based drugmaker reaffirmed that it expects to receive approval from regulators for its respiratory syncytial virus (RSV) vaccine in time for it ...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 1 day agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
RFK Jr. repeats debunked vaccine claims in interview with Bill Maher
Salon.com· 5 days agoPresidential hopeful Robert F. Kennedy Jr. made an appearance on “Real Time with Bill Maher” on...
Moderna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 13 hours agoModerna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall
New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
PA Media: Science via Yahoo News· 1 day agoAlthough it is too early to assess the clinical effects of the vaccine, the patients in the new...
Moderna cancer vaccine offers long-term hope in melanoma
Proactive Investors· 7 days agoCovid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 7 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...